LEGN Nov 2024 70.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 09:49AM EDT. Market open.
| Previous Close | 2.0000 |
| Open | 2.0000 |
| Bid | 0.0500 |
| Ask | 3.3000 |
| Strike | 70.00 |
| Expire Date | 2024-11-15 |
| Day's Range | 2.0000 - 2.0000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 1 |
Business WireLegend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
SOMERSET, N.J., May 23, 2024--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today that new and updated data from the CARTITUDE clinical development program evaluating CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) for patients with multiple myeloma will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and the 2024 European Hematology Association’s (EHA) Hybrid Congress.
- GuruFocus.com
Legend Biotech Corp (LEGN) Q1 2024 Earnings Call Transcript Highlights: Soaring CARVYKTI Sales ...
Discover how Legend Biotech's robust Q1 performance and strategic initiatives are setting the stage for sustained growth.
- Thomson Reuters StreetEvents
Q1 2024 Legend Biotech Corp Earnings Call
Q1 2024 Legend Biotech Corp Earnings Call
© 2024 Yahoo. All rights reserved.